{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:20:07Z","timestamp":1719966007821},"reference-count":20,"publisher":"Academy of Managed Care Pharmacy","issue":"7-a Suppl","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.18553\/jmcp.2024.30.7-a.s1","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:27:41Z","timestamp":1719919661000},"page":"S1-S12","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing the management of inherited blood disorders in a changing market: Findings from the AMCP Market Insights Program"],"prefix":"10.18553","volume":"30","author":[{"given":"Terry","family":"Richardson","sequence":"first","affiliation":[{"name":"Impact Education, LLC, Blue Bell, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Rice","sequence":"additional","affiliation":[{"name":"Michelle Rice and Associates, LLC, Scottsdale, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Haumschild","sequence":"additional","affiliation":[{"name":"Emory Healthcare and Winsor Cancer Institute, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Hoffer","sequence":"additional","affiliation":[{"name":"CompanionCARE, Columbia, SC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sal","family":"Morana","sequence":"additional","affiliation":[{"name":"Alliant Employee Benefits, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Watkins","sequence":"additional","affiliation":[{"name":"Managed Care Perspectives, LLC, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003424"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189287"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21408"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02545-7"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2014-0171"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-12-200806170-00220"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.921432"},{"key":"R15","author":"Beaudoin FL","year":"2022","journal-title":"Final Evidence Report. Institute for Clinical and Economic Review"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000852180.45597.87"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162380"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211075"},{"key":"R20","author":"Tice JA","year":"2022","journal-title":"Final Evidence Report"},{"key":"R21","author":"Miesbach W","year":"2022","journal-title":"Presented at: The European Association for Haemophilia and Allied Disorders (EAHAD)"},{"key":"R22","author":"Locatelli F","year":"2021","journal-title":"Presented at: European Hematology Association"},{"issue":"2","key":"R25","first-page":"437","volume":"96","author":"Soucie JM","year":"2000","journal-title":"Blood"},{"key":"R26","unstructured":"Mercer. Health benefit cost expected to rise 5.4% in 2024. Published September 7, 2023. Accessed November 2023. https:\/\/www.mercer.com\/en-us\/insights\/us-health-news\/health-benefit-cost-expected-to-rise-54-in-2024-mercer-survey\/"},{"key":"R31","unstructured":"Ciarametaro M, Long G, Johnson M, Kirson N, Dubois RW. Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy? Health Affairs. Published June 28, 2018. Accessed November 2023. https:\/\/www.healthaffairs.org\/content\/forefront\/payers-ready-address-financial-challenges-associated-gene-therapy"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxad043"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:27:49Z","timestamp":1719919669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2024.30.7-a.s1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":20,"journal-issue":{"issue":"7-a Suppl","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.18553\/jmcp.2024.30.7-a.s1"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2024.30.7-a.s1","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}